-
Je něco špatně v tomto záznamu ?
Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer
J. Kumar, D. Chudasama, C. Roberts, M. Kubista, R. Sjöback, J. Chatterjee, V. Anikin, E. Karteris, M. Hall,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2012
Free Medical Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-03-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
31319587
DOI
10.3390/cells8070732
Knihovny.cz E-zdroje
- MeSH
- antigeny CD45 metabolismus MeSH
- karcinom krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádorové biomarkery metabolismus MeSH
- nádorové buněčné linie MeSH
- nádorové cirkulující buňky metabolismus patologie MeSH
- nádory vaječníků krev MeSH
- proteiny WT1 metabolismus MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
:Background: Current diagnosis and staging of advanced epithelial ovarian cancer (aEOC) has important limitations and better biomarkers are needed. We investigate the performance of non-haematopoietic circulating cells (CCs) at the time of disease presentation and relapse. Methods: Venous blood was collected prospectively from 37 aEOC patients and 39 volunteers. CCs were evaluated using ImageStream TechnologyTM and specific antibodies to differentiate epithelial cells from haematopoetic cells. qRT-PCR from whole blood of relapsed aEOC patients was carried out for biomarker discovery. Results: Significant numbers of CCs (CK+/WT1+/CD45-) were identified, quantified and characterised from aEOC patients compared to volunteers. CCs are abundant in women with newly diagnosed aEOC, prior to any treatment. Evaluation of RNA from the CCs in relapsed aEOC patients (n = 5) against a 79-gene panel revealed several differentially expressed genes compared to volunteers (n = 14). Size differentiation of CCs versus CD45+ haematopoietic cells was not reliable. Conclusion: CCs of non-haematopoetic origin are prevalent, particularly in patients with newly diagnosed aEOC. Exploiting a CC-rich population in aEOC patients offers insights into a part of the circulating microenvironment.
Department Life Sciences Brunel University London Uxbridge UB8 3PH UK
Mount Vernon Cancer Centre Middlesex HA6 2RN UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006136
- 003
- CZ-PrNML
- 005
- 20200528094352.0
- 007
- ta
- 008
- 200511s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cells8070732 $2 doi
- 035 __
- $a (PubMed)31319587
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kumar, Juhi $u Department Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK.
- 245 10
- $a Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer / $c J. Kumar, D. Chudasama, C. Roberts, M. Kubista, R. Sjöback, J. Chatterjee, V. Anikin, E. Karteris, M. Hall,
- 520 9_
- $a :Background: Current diagnosis and staging of advanced epithelial ovarian cancer (aEOC) has important limitations and better biomarkers are needed. We investigate the performance of non-haematopoietic circulating cells (CCs) at the time of disease presentation and relapse. Methods: Venous blood was collected prospectively from 37 aEOC patients and 39 volunteers. CCs were evaluated using ImageStream TechnologyTM and specific antibodies to differentiate epithelial cells from haematopoetic cells. qRT-PCR from whole blood of relapsed aEOC patients was carried out for biomarker discovery. Results: Significant numbers of CCs (CK+/WT1+/CD45-) were identified, quantified and characterised from aEOC patients compared to volunteers. CCs are abundant in women with newly diagnosed aEOC, prior to any treatment. Evaluation of RNA from the CCs in relapsed aEOC patients (n = 5) against a 79-gene panel revealed several differentially expressed genes compared to volunteers (n = 14). Size differentiation of CCs versus CD45+ haematopoietic cells was not reliable. Conclusion: CCs of non-haematopoetic origin are prevalent, particularly in patients with newly diagnosed aEOC. Exploiting a CC-rich population in aEOC patients offers insights into a part of the circulating microenvironment.
- 650 _2
- $a nádorové biomarkery $x metabolismus $7 D014408
- 650 _2
- $a karcinom $x krev $7 D002277
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a antigeny CD45 $x metabolismus $7 D017493
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nádorové cirkulující buňky $x metabolismus $x patologie $7 D009360
- 650 _2
- $a nádory vaječníků $x krev $7 D010051
- 650 _2
- $a proteiny WT1 $x metabolismus $7 D025721
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Chudasama, Dimple $u Department Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK.
- 700 1_
- $a Roberts, Charlotte $u Mount Vernon Cancer Centre, Middlesex HA6 2RN, UK.
- 700 1_
- $a Kubista, Mikael $u TATAA Biocenter, 411 03 Göteborg, Sweden. Laboratory of Gene Expression, Institute of Biotechnology CAS, v.v.i., 252 50 Vestec, Czech Republic.
- 700 1_
- $a Sjöback, Robert $u TATAA Biocenter, 411 03 Göteborg, Sweden.
- 700 1_
- $a Chatterjee, Jayanta $u Faculty of Health and Medical Sciences, School of Biosciences and Medicine, University of Surrey, Guildford, Surrey GU2 7XH, UK.
- 700 1_
- $a Anikin, Vladimir $u Department Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK. Division of Thoracic Surgery, The Royal Brompton & Harefield NHS Foundation Trust, Harefield Hospital, London UB9 6JH, UK. Department of Oncology and Reconstructive Surgery, Sechenov First Moscow State Medical University, 119146 Moscow, Russia.
- 700 1_
- $a Karteris, Emmanouil $u Department Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK. emmanouil.karteris@brunel.ac.uk.
- 700 1_
- $a Hall, Marcia $u Department Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK. marcia.hall@nhs.net. Mount Vernon Cancer Centre, Middlesex HA6 2RN, UK. marcia.hall@nhs.net.
- 773 0_
- $w MED00194911 $t Cells $x 2073-4409 $g Roč. 8, č. 7 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31319587 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200528094350 $b ABA008
- 999 __
- $a ok $b bmc $g 1524994 $s 1096192
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 8 $c 7 $e 20190717 $i 2073-4409 $m Cells $n Cells $x MED00194911
- LZP __
- $a Pubmed-20200511